Candida auris rapid test Vivalytic

for infectious diseasesnasalfor anal swab

Candida auris is an emerging and often multidrug-resistant fungal species that poses a significant threat to public health. This yeast-like fungus can cause severe infections, primarily affecting individuals with compromised immune systems, those in healthcare facilities, or those with underlying medical conditions. Candida auris is particularly concerning due to its ability to persist on surfaces, leading to healthcare-associated outbreaks. Diagnosis can be challenging as it is often misidentified with other Candida species. Effective management involves prompt identification, strict infection control measures followed by treatment. The Vivalytic Candida auris test is an automated, qualitative in vitro diagnostic employing real-time PCR to detect Candida auris DNA from swabs taken from the human axilla, groin, nasal, and rectal areas. This test serves to screen individuals at risk for colonisation, playing a crucial role in the prevention and control of Candida auris outbreaks and infections within healthcare settings. Learn about the transformative impact of switching from culture-based testing to PCR for managing Candida auris at Guy’s and St Thomas’ NHS Foundation Trust. Qualitative RT-PCR detection of Candida auris Quick turnaround time of less than 1 hour, beneficial for both the patient and for the containment of Candida and reducing transmission. Convenient 4 step process from sample entry to results. Suitable for use in laboratory and non-laboratory settings. Real-time PCR enables rapid and targeted detection up to 4 weeks after the onset of symptoms of the multidrug-resistant fungal Candida.